These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 25222075

  • 1. Influence of Comorbidity on the Risk of Death: A Single Institution Study of 1132 Women With Early-stage Uterine Cancer.
    Elshaikh MA, Vance S, Kamal M, Burmeister C, Hanna RK, Rasool N, Siddiqui F.
    Am J Clin Oncol; 2017 Apr; 40(2):183-188. PubMed ID: 25222075
    [Abstract] [Full Text] [Related]

  • 2. Impact of age-adjusted Charlson comorbidity score on outcomes for patients with early-stage endometrial cancer.
    Robbins JR, Gayar OH, Zaki M, Mahan M, Buekers T, Elshaikh MA.
    Gynecol Oncol; 2013 Dec; 131(3):593-7. PubMed ID: 24125752
    [Abstract] [Full Text] [Related]

  • 3. Predictive Capacity of 3 Comorbidity Indices in Estimating Survival Endpoints in Women With Early-Stage Endometrial Carcinoma.
    Al Feghali KA, Robbins JR, Mahan M, Burmeister C, Khan NT, Rasool N, Munkarah A, Elshaikh MA.
    Int J Gynecol Cancer; 2016 Oct; 26(8):1455-60. PubMed ID: 27488218
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A Matched Analysis on the Prognostic Impact of Race on Survival Endpoints of Women with Early-Stage Endometrial Cancer.
    Feldman A, Chaugle S, Burmeister C, Munkarah A, Elshaikh MA.
    Gynecol Obstet Invest; 2019 Oct; 84(3):283-289. PubMed ID: 30540995
    [Abstract] [Full Text] [Related]

  • 7. The impact of lymphadenectomy on survival endpoints in women with early stage uterine endometrioid carcinoma: A matched analysis.
    Ghanem AI, Khan NT, Mahan M, Ibrahim A, Buekers T, Elshaikh MA.
    Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():225-230. PubMed ID: 28068595
    [Abstract] [Full Text] [Related]

  • 8. Improved survival endpoints with adjuvant radiation treatment in patients with high-risk early-stage endometrial carcinoma.
    Elshaikh MA, Vance S, Suri JS, Mahan M, Munkarah A.
    Int J Radiat Oncol Biol Phys; 2014 Feb 01; 88(2):351-6. PubMed ID: 24411608
    [Abstract] [Full Text] [Related]

  • 9. Survival endpoints for young women with early stage uterine endometrioid carcinoma: a matched analysis.
    Isrow D, Burmeister C, Hanna RK, Elshaikh MA.
    Eur J Obstet Gynecol Reprod Biol; 2016 Dec 01; 207():115-120. PubMed ID: 27838535
    [Abstract] [Full Text] [Related]

  • 10. Is Older Age a Real Adverse Prognostic Factor in Women With Early-Stage Endometrial Carcinoma? A Matched Analysis.
    Haley L, Burmeister C, Buekers T, Elshaikh MA.
    Int J Gynecol Cancer; 2017 Mar 01; 27(3):479-485. PubMed ID: 28060139
    [Abstract] [Full Text] [Related]

  • 11. The prognostic significance of age in surgically staged patients with Type II endometrial carcinoma.
    Vance S, Yechieli R, Cogan C, Hanna R, Munkarah A, Elshaikh MA.
    Gynecol Oncol; 2012 Jul 01; 126(1):16-9. PubMed ID: 22507535
    [Abstract] [Full Text] [Related]

  • 12. Recurrence patterns and survival endpoints in women with stage II uterine endometrioid carcinoma: a multi-institution study.
    Elshaikh MA, Al-Wahab Z, Mahdi H, Albuquerque K, Mahan M, Kehoe SM, Ali-Fehmi R, Rose PG, Munkarah AR.
    Gynecol Oncol; 2015 Feb 01; 136(2):235-9. PubMed ID: 25511158
    [Abstract] [Full Text] [Related]

  • 13. Hysterectomy for uterine adenocarcinoma in the elderly: tumor characteristics, and long-term outcome.
    Gayar OH, Robbins JR, Parikh K, Lu M, Buekers T, Munkarah A, Elshaikh MA.
    Gynecol Oncol; 2011 Oct 01; 123(1):71-5. PubMed ID: 21767871
    [Abstract] [Full Text] [Related]

  • 14. Does the Interval Between Hysterectomy and Start of Adjuvant Radiation Treatment Influence Survival in Women With Endometrial Carcinoma?: A National Cancer Database analysis.
    Ghanem AI, Modh A, Burmeister C, Mahmoud O, Elshaikh MA.
    Am J Clin Oncol; 2020 Aug 01; 43(8):602-606. PubMed ID: 32398405
    [Abstract] [Full Text] [Related]

  • 15. The Prognostic Significance of the Depth of Cervical Stromal Invasion in Women With FIGO Stage II Uterine Endometrioid Carcinoma.
    Al Khatib S, Bhatnagar A, Elshaikh N, Ghanem AI, Burmeister C, Allo G, Alkamachi B, Paridon A, Elshaikh MA.
    Am J Clin Oncol; 2023 Oct 01; 46(10):445-449. PubMed ID: 37525355
    [Abstract] [Full Text] [Related]

  • 16. Analysis of prognostic variables, development of predictive models, and stratification of risk groups in surgically treated FIGO early-stage (IA-IIA) carcinoma cervix.
    Singh P, Tripcony L, Nicklin J.
    Int J Gynecol Cancer; 2012 Jan 01; 22(1):115-22. PubMed ID: 21997176
    [Abstract] [Full Text] [Related]

  • 17. Survival impact of cytoreduction to microscopic disease for advanced stage cancer of the uterine corpus: a retrospective cohort study.
    Alagkiozidis I, Grossman A, Tang NZ, Weedon J, Mize B, Salame G, Lee YC, Abulafia O.
    Int J Surg; 2015 Feb 01; 14():61-6. PubMed ID: 25576762
    [Abstract] [Full Text] [Related]

  • 18. New online dynamic nomograms to predict recurrence-free and overall survival after resection of endometrial cancer: a single-institution retrospective cohort study.
    Hu Z, Li J, Du J.
    Arch Gynecol Obstet; 2024 Nov 01; 310(5):2603-2615. PubMed ID: 38886217
    [Abstract] [Full Text] [Related]

  • 19. Obesity and Lymphovascular Invasion in Women with Uterine Endometrioid Carcinoma.
    Kamal M, Burmeister C, Zhang Z, Munkarah A, Elshaikh MA.
    Anticancer Res; 2015 Jul 01; 35(7):4053-7. PubMed ID: 26124354
    [Abstract] [Full Text] [Related]

  • 20. Histological grade predicts for recurrence in patients with uterine endometrioid carcinoma without myometrial involvement.
    Zaki MA, Robbins JR, Fatteh S, Mahan MG, Hanna RK, Elshaikh MA.
    Anticancer Res; 2012 Sep 01; 32(9):4061-5. PubMed ID: 22993361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.